gLike
RSA
RSA DESIGN BRIEF - Patients with asthma avoid using inhalers or cut down their dose because they cannot afford prescription charges.
GlaxoSmithKline manufactures 200 million inhalation aerosols a year. The inhalers are not recyclable and end up in landfill or for incineration.
(Andrew Grant, Director, Worldwide Device Technology, GlaxoSmithKline Research & development)
My task to come up with a new asthma pump that could be re-used can be recycled and is cheap to buy